Claudio Cafiero

This inventor holds 8 USPTO granted patents, plus 3 CIPO patents and 6 EPO patents. Top assignee: Chiesi Farmaceutici S.p.a.. Active years: 2016-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Claudio Cafiero. Retrieved from https://idiyas.com/inventor/claudio-cafiero

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 8

% Patents Active = 100.0

CIPO Patents = 3 (Patent Applications = 1)

EPO Patents = 6 (Patent Applications = 6)

Average Co-Inventor Count = 2.4

ph-index = 1

Forward Citations = 1(Granted Patents)

Company Filing History:

8 out of 343

Chiesi Farmaceutici S.p.a.

patents

Years Active: 2016-2023

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11628175 - Process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic (2023-04-18),

2. 10966991 - Process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic (2021-04-06),

3. 10959944 - Process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic (2021-03-30),

4. 10786451 - Process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic (2020-09-29),

5. 10772896 - Process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic (2020-09-15),

6. 10086004 - Process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic (2018-10-02),

7. 10086003 - Process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic (2018-10-02),

8. 9427376 - Process for preparing pharmaceutical formulations for inhalation comprising a high-dosage strength active ingredient (2016-08-30),

Title: The Innovations of Claudio Cafiero

Introduction

Claudio Cafiero is a notable inventor based in Parma, Italy, recognized for his contributions to pharmaceutical formulations. With a total of 8 patents to his name, he has made significant strides in the field of respiratory medicine.

Latest Patents

Cafiero's latest patents include a process for preparing a dry powder formulation that combines an anticholinergic, a corticosteroid, and a beta-adrenergic. These dry powder formulations for inhalation are designed to be effective in the prevention and treatment of inflammatory and obstructive airways diseases. His innovative approach aims to enhance the delivery and efficacy of medications for patients suffering from respiratory conditions.

Career Highlights

Cafiero is currently employed at Chiesi Farmaceutici S.p.a., a company known for its focus on developing innovative solutions in the pharmaceutical industry. His work has been instrumental in advancing the understanding and treatment of respiratory diseases, showcasing his commitment to improving patient outcomes.

Collaborations

Some of his notable coworkers include Leonardo Ortenzi and Francesca Schiaretti, who have collaborated with him on various projects within the company. Their teamwork has contributed to the successful development of new pharmaceutical formulations.

Conclusion

Claudio Cafiero's work exemplifies the impact of innovation in the pharmaceutical industry, particularly in the realm of respiratory health. His patents and collaborations reflect a dedication to enhancing treatment options for patients worldwide.

Profile summary based on public USPTO records.